What is the most likely diagnosis for an elderly patient with confusion, epigastric discomfort, abnormal liver function tests, raised CRP, gallstones, and a mildly dilated common bile duct?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Diagnosis: Cholangitis

The most likely diagnosis is cholangitis (Option B), given the combination of confusion (sepsis-related), markedly elevated inflammatory markers (CRP 120 mg/L), obstructive liver function test pattern (bilirubin 120 μmol/L, ALP 750 IU/L), and dilated common bile duct in an elderly patient with gallstones.

Clinical Reasoning

Key Diagnostic Features Supporting Cholangitis

  • Confusion in an elderly patient with elevated CRP (120 mg/L) strongly suggests systemic infection/sepsis, which is the hallmark of cholangitis rather than simple cholecystitis 1

  • The obstructive pattern of liver enzymes is critical: bilirubin of 120 μmol/L (approximately 7 mg/dL) with ALP 750 IU/L indicates biliary obstruction with infection 1

  • Dilated common bile duct without visible stones on ultrasound does not exclude cholangitis—ultrasound has only 73% sensitivity for detecting common bile duct stones, and stones may have passed or be intermittently obstructing 1

Risk Stratification for Common Bile Duct Stones

According to the modified ASGE criteria, this patient falls into the high-risk category for choledocholithiasis based on:

  • Bilirubin > 4 mg/dL (approximately 68 μmol/L) - this patient has 120 μmol/L (approximately 7 mg/dL) 1, 2
  • Dilated common bile duct on ultrasound 1
  • Clinical picture consistent with ascending cholangitis (confusion, elevated inflammatory markers) 1, 3

High-risk patients have a >50% probability of having common bile duct stones and should proceed directly to therapeutic ERCP 1, 3

Why Not the Other Options?

Cholecystitis (Option C) - Less Likely

  • Cholecystitis typically presents with right upper quadrant pain and fever, not confusion 1
  • The degree of hyperbilirubinemia (120 μmol/L) is excessive for simple cholecystitis—cholecystitis usually causes mild bilirubin elevation if any 1
  • CRP of 120 mg/L with confusion suggests systemic sepsis from biliary infection (cholangitis) rather than localized gallbladder inflammation 1

Ampullary Carcinoma (Option A) - Unlikely

  • Malignant obstruction typically presents with painless progressive jaundice, not acute confusion with high inflammatory markers 1
  • The presence of gallstones makes a calculous etiology far more likely in this acute presentation 4

Pancreatic Carcinoma (Option D) - Unlikely

  • Similar to ampullary carcinoma, pancreatic cancer presents with painless jaundice and weight loss, not acute septic picture 1
  • CRP of 120 mg/L is inconsistent with malignant obstruction 1

Primary Sclerosing Cholangitis (Option E) - Unlikely

  • PSC is a chronic progressive disease diagnosed by MRCP showing characteristic beading and strictures of bile ducts 1, 5, 6
  • PSC typically presents with chronic elevation of ALP discovered on routine screening, not acute confusion and sepsis 1, 7
  • PSC is strongly associated with inflammatory bowel disease (71% of cases), which is not mentioned in this patient 7, 8

Immediate Management Approach

This patient requires urgent intervention for suspected cholangitis:

  • Initiate broad-spectrum antibiotics immediately for ascending cholangitis 2
  • Proceed directly to ERCP given high-risk criteria (bilirubin >4 mg/dL and dilated CBD) without need for additional imaging 1, 2
  • Blood cultures should be obtained before antibiotics 2

Common Pitfall to Avoid

Do not delay ERCP to obtain MRCP or EUS in high-risk patients—the 2020 World Society of Emergency Surgery guidelines emphasize that patients meeting high-risk criteria (visible CBD stone on ultrasound OR bilirubin >4 mg/dL with dilated CBD) should proceed directly to therapeutic ERCP 1. Additional imaging only delays definitive treatment and increases morbidity in septic patients 1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.